Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Health and social care could account for half of UK government spending by 2060

King’s Fund report comes as health secretary announces South London NHS Trust to be dissolved

- PMLiVE

AbbVie expects Humira to drive growth in inaugural guidance

First statement since split from Abbott

- PMLiVE

EC to investigate Novartis and J&J in antitrust probe

Claims companies agreed to delay entry of generic painkiller

- PMLiVE

Jonathan Fox leaves AstraZeneca for MyoKardia

Will lead programme to target genetic heart disease

- PMLiVE

NICE turns down diabetes and ovarian cancer drugs for NHS use

Disappointment for BMS/AZ’s Forxiga and Roche’s Avastin

EU flag

European CRO market set to reach $11.54bn by 2018

Frost and Sullivan expects outsourcing efforts to increase

- PMLiVE

AZ swipes Fishburn Hedge’s healthcare lead

Ayesha Bharmal joins the pharma company as global media relations director

- PMLiVE

Is the single-minded proposition fit for 2013?

Thought Leader: A single-minded proposition may be reductionist, but a good one will contain a necessary tension that can be explored

- PMLiVE

inVentiv renames its CRO as inVentiv Health Clinical

Aligning company’s clinical segment with its commercial services

Bedrock hires new client services director

Patricia Forsyth joins from Acumed

- PMLiVE

Bayer’s Diane 35 faces ban in France

Follows investigation into blood clot-related deaths

- PMLiVE

FDA advisors back Boehringer’s COPD drug olodaterol

Committee votes 15 to 1 in favour despite cancer concerns

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links